Can Compounding Pharmacies Still Make Semaglutide? FDA Rules Explained
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
Learn about the FDA's rules on compounded semaglutide, the difference between 503A and 503B pharmacies, and the risks of using non-FDA-approved drugs.
Can Compounding Pharmacies Still Make Semaglutide? FDA Rules Explained
The question of whether compounded semaglutide is legal has become a significant topic of discussion among patients and healthcare providers. With the rising popularity of GLP-1 agonists for weight loss and diabetes management, understanding the nuances of FDA regulations is crucial. This article delves into the rules governing compounding pharmacies, the safety concerns associated with compounded semaglutide, and the current legal landscape.
A Brief History of Drug Compounding
The practice of drug compounding dates back to ancient times, when pharmacists, known as apothecaries, would prepare customized medications for individual patients. This tradition continued for centuries, with compounding being the standard for pharmaceutical care. However, with the rise of mass-produced medications in the 20th century, the role of the compounding pharmacist shifted to a more specialized practice. 6
The FDA's Stance on Drug Compounding
The FDA has clear guidelines regarding drug compounding, which is the process of creating a medication for an individual patient by a licensed pharmacist or physician. While compounding serves an important role in medicine, particularly for patients who have specific needs that cannot be met by commercially available drugs, it is not without its risks. Compounded drugs are not FDA-approved, meaning they have not undergone the same rigorous testing for safety, efficacy, and quality as their FDA-approved counterparts. 1
The Federal Food, Drug, and Cosmetic (FD&C) Act outlines the conditions under which compounding is permitted. The two primary sections governing compounding are 503A and 503B.
Section 503A applies to state-licensed pharmacies and physicians. A key restriction under this section is on compounding drugs that are "essentially copies" of commercially available drugs, especially when a drug is no longer on the FDA's drug shortage list.
Section 503B applies to outsourcing facilities, which are held to a higher standard and must comply with current Good Manufacturing Practice (cGMP) regulations. These facilities are also restricted from compounding drugs that are essentially copies of FDA-approved drugs, unless the approved drug is on the shortage list.
503A vs. 503B Compounding Pharmacies: What's the Difference?
To better understand the regulatory landscape, it's important to distinguish between 503A and 503B compounding pharmacies.
| Feature | 503A Compounding Pharmacy | 503B Outsourcing Facility |
| :--- | :--- | :--- |
| Regulation | State boards of pharmacy | FDA and state boards of pharmacy |
| Prescription | Requires a patient-specific prescription | Can produce for office use without a prescription |
| Manufacturing Standards | USP <795> and <797> | cGMP |
| Batch Size | Small batches | Large batches |
Is Compounded Semaglutide Legal? A Complex Issue
The legality of compounded semaglutide hinges on several factors, including drug shortages and the specific ingredients used. For a period, semaglutide was on the FDA's drug shortage list, which allowed compounding pharmacies to produce the medication to meet patient demand. However, as the supply of FDA-approved semaglutide has stabilized, the legal basis for compounding it has narrowed significantly. 1
Furthermore, the FDA has raised concerns about the use of salt forms of semaglutide, such as semaglutide sodium and semaglutide acetate, in compounded products. The agency has stated that these salt forms are different active ingredients than what is used in the approved drugs, and their safety and effectiveness have not been established. 2
If you are considering peptide therapy or have questions about weight management, the specialists at TeleGenix can help you navigate your options and create a personalized treatment plan.
Understanding Semaglutide Base vs. Salt Forms
Another critical aspect to consider is the chemical composition of the compounded semaglutide. FDA-approved semaglutide drugs contain semaglutide base. However, some compounding pharmacies use salt forms, such as semaglutide sodium or semaglutide acetate. The FDA has explicitly stated that these salt forms are different active ingredients and have not been shown to be safe or effective. 2
| Form | Chemical Composition | FDA Approval Status |
| :--- | :--- | :--- |
| Semaglutide Base | The active ingredient in FDA-approved drugs | Approved |
| Semaglutide Sodium | A salt form of semaglutide | Not approved, safety and efficacy not established |
| Semaglutide Acetate | A salt form of semaglutide | Not approved, safety and efficacy not established |
Risks Associated with Compounded Semaglutide
The lack of FDA oversight for compounded drugs introduces potential risks. The FDA has received numerous reports of adverse events associated with compounded semaglutide, some of which required hospitalization. 3 Administration errors are also a significant concern. 4 PMID: 40285721 These risks can stem from a variety of factors, including:
Incorrect dosage: Compounded drugs may have a different strength than the FDA-approved version, leading to under- or over-dosing.
Contamination: Compounded drugs are not subject to the same stringent manufacturing standards, which can increase the risk of contamination.
Different active ingredients: As mentioned, some compounders may use salt forms of semaglutide, which have not been proven to be safe or effective.
FDA-Approved vs. Compounded Semaglutide
To better understand the differences, here is a comparison of FDA-approved and compounded semaglutide:
| Feature | FDA-Approved Semaglutide | Compounded Semaglutide |
| :--- | :--- | :--- |
| FDA Approval | Yes | No |
| Safety and Efficacy | Proven through clinical trials | Unknown |
| Manufacturing Standards | cGMP | Varies, not always cGMP |
| Active Ingredient | Semaglutide | May be semaglutide or a salt form |
| Legal Status | Legal | Legal only in specific circumstances (e.g., drug shortage) |
For more information on peptide therapies, you can explore our peptide therapy guide.
Navigating Your Options
Given the potential risks and legal gray areas, it is essential for patients to be well-informed. If you are considering semaglutide for weight loss or diabetes, the safest option is to use an FDA-approved product. If you are considering a compounded version, it is crucial to have an open discussion with your healthcare provider about the potential risks and benefits. You can also learn more about different treatment options in our conditions library.
For those interested in exploring other options, our compounds library and testosterone library provide valuable information. You can also use our comparison tool to evaluate different treatments or find a provider for TRT near you.
The specialists at TeleGenix can help you make an informed decision about your health and wellness journey.
How to Report Adverse Events
If you have experienced any adverse events while using a compounded semaglutide product, it is crucial to report them to the FDA. The FDA's MedWatch program allows healthcare professionals and consumers to report serious problems with medical products. 5
The Role of the Prescriber
Prescribers also have a significant responsibility when it comes to compounded medications. They must have a thorough understanding of the patient's medical needs and be able to justify why a compounded drug is necessary over an FDA-approved alternative. The prescriber is also responsible for the safety and efficacy of the prescribed compounded drug.
How to Identify a Legitimate Compounding Pharmacy
If you and your healthcare provider decide that a compounded medication is the right choice for you, it is important to use a reputable and licensed compounding pharmacy. Here are some tips for identifying a legitimate compounding pharmacy:
Check for accreditation: Look for accreditation from organizations like the Pharmacy Compounding Accreditation Board (PCAB).
Verify licensing: Ensure the pharmacy is licensed by the state board of pharmacy.
Ask questions: Don't hesitate to ask the pharmacist about their compounding practices, including the source of their ingredients and their quality control procedures.
The Future of GLP-1 Compounding and Legal Actions
As the demand for GLP-1 agonists continues to grow, the future of compounded versions remains uncertain. With the resolution of the semaglutide shortage, the FDA is expected to increase its enforcement actions against compounding pharmacies that are not in compliance with federal law. 7
Pharmaceutical companies like Novo Nordisk, the manufacturer of Ozempic and Wegovy, have also taken legal action against compounding pharmacies and other entities that they allege are selling unapproved and misbranded products. These lawsuits aim to protect patients from potentially unsafe and ineffective drugs and to safeguard their intellectual property rights. 8
Conclusion
While compounding pharmacies play a vital role in healthcare, the use of compounded semaglutide is a complex issue. The legality is largely dependent on the FDA's drug shortage list and the specific active ingredients used. Given the potential safety concerns and the lack of FDA approval, patients should exercise caution and consult with a qualified healthcare provider to determine the best course of action for their individual needs.
References
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment.
---